Yunhui Cheng

6.0k citations
34 papers · 4.7k indexed · 2 hit papers · h-index 24

Yunhui Cheng

32 papers receiving 4.7k citations

Hit Papers

MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marke...5492007202620132019250500750

Peers

Yunhui Cheng
Comparison fields: 5 of 117
  • Cancer Research 3.3k
  • Molecular Biology 3.6k
  • Cardiology and Cardiovascular Medicine 446
  • Developmental Neuroscience 62
  • Immunology 310
Replace Xiaojun Liu with:
Xiaojun Liu China
Simona Greco Italy
Yaoliang Tang United States
Zhenwei Pan China
Masamichi Koyanagi Japan
Jinghai Chen China
Felix Jansen Germany
Sergio Caballero United States
SF Chen China
Yunhui Cheng relative to Xiaojun Liu China Xiaojun Liu's profile →
Citations per field
00.5×1.6×
Xiaojun Liu · 1×
Citations per year

Countries citing papers authored by Yunhui Cheng

Since Specialization
Citations

This map shows the geographic impact of Yunhui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunhui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunhui Cheng more than expected).

Fields of papers citing papers by Yunhui Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunhui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunhui Cheng. The network helps show where Yunhui Cheng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yunhui Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yunhui Cheng Line = papers co-authored together Yunhui Cheng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20230
3 202248
4 201623
5 201360
6 2012140
7 201182
8 201115
9 2010101
10 2010283
11 2010278
12 201051
13 200933
14 2009393
15 2009202
16 2009319
17 200818
18 2007416
19 2006106
20 200626

About Yunhui Cheng

Yunhui Cheng is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy, having authored 34 papers that have together received 4.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Circular RNAs in diseases (15 papers), Cancer-related molecular mechanisms research (11 papers), Nitric Oxide and Endothelin Effects (3 papers), Advanced Breast Cancer Therapies (2 papers), Extracellular vesicles in disease (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Cancer Research (3.3k citations), Molecular Biology (3.6k citations) and Cardiology and Cardiovascular Medicine (446 citations). Yunhui Cheng has collaborated with scholars based in United States, China and Brazil. Frequent co-authors include Chunxiang Zhang, Jian Yang, Xiaojun Liu, Ying Lin, Ruirui Ji, Junming Yue, He Chen, Shuo Zhang, Xiaojun Liu and Ellise Delphin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026